Didem Tecİmel

6PUBLICATIONS
15CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 09, 2026
Correction: Connexin 43 inhibitors reduce cell viability in glioblastoma and astrocyte co-culture systems.

Ali Genc, Berfin Uzunkaya, Gizem InetasYengin

|Nov 13, 2025
Differential modulation of cisplatin efficacy by montelukast sodium and desloratadine in lung cancer.

Seha Akduman, Büşra Yüksel, Didem Tecimel

|Sep 01, 2025
Loss of CD90 alters EMT-associated features and drug sensitivity in U-CH1 chordoma cells.

Didem Tecimel, Nur Ekimci Gürcan, Didem Seven

|Aug 07, 2025
Connexin 43 inhibitors reduce cell viability in glioblastoma and astrocyte co-culture systems.

Ali Genc, Berfin Uzunkaya, Gizem Inetas Yengin

|Jan 18, 2023
Impact of silencing eEF2K expression on the malignant properties of chordoma.

Esra Aydemir, Emre Can Tüysüz, Ömer Faruk Bayrak

|Oct 28, 2020
E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells.

Esra Aydemİr Çoban, Didem Tecİmel, Ezgi KaŞikci

Pageof 1